Market Cap

Daito Pharmaceutical Co.,Ltd. Market Capitalization:

€358.2 Million

EUR as of Aug. 1, 2021

US$425.2 Million

business Daito Pharmaceutical Co.,Ltd. Company Profile

Daito Pharmaceutical Co.,Ltd. Main Stock Listing

FSX: DPA

Market Capitalization History of Daito Pharmaceutical Co.,Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Daito Pharmaceutical Co.,Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2021 €400.1 M 0.00%
Jan. 1, 2020 €400.1 M 31.37%
Jan. 1, 2019 €304.6 M -19.07%
Jan. 1, 2018 €376.4 M 49.60%
Jan. 1, 2017 €251.6 M -17.31%
Jan. 1, 2016 €304.2 M 31.48%
Jan. 1, 2015 €231.4 M 69.01%
Jan. 1, 2014 €136.9 M -7.34%
Jan. 1, 2013 €147.8 M 2.87%
Jan. 1, 2012 €143.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Daito Pharmaceutical Co.,Ltd. Categories

Japan languages Healthcare languages Drug Manufacturers—Specialty & Generic
Japan Healthcare Japan Drug Manufacturers—Specialty & Generic

Stocks & Indices

Daito Pharmaceutical Co.,Ltd. has the following listings and related stock indices.


Stock: FSX: DPA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.